Genesis HealthCare, once one of the largest nursing home operators in the country, filed for Chapter 11 bankruptcy on July 9, 2025, freezing payment on roughly 1,000 settled and pending lawsuits over patient injuries and deaths. The Genesis HealthCare lawsuit picture now runs on two tracks: a bankruptcy sale that will determine how much money reaches families, and a separate fraud suit against the private equity insiders who controlled the company. After a judge rejected an initial insider buyback, a new $1.015 billion sale approved in January 2026 is expected to return around 30 cents on the dollar to junior creditors, including personal injury and wrongful death claimants.1https://www.privateequitystakeholder.org/
What the Lawsuits Allege
When Genesis entered bankruptcy, it estimated liability across about 1,000 settled and pending suits at $259 million, with another $344 million in potential exposure from 165 additional claims. The complaints describe untreated bedsores, falls, infections, medication errors, malnutrition, dehydration, and physical and sexual abuse in Genesis facilities.
One Philadelphia case that reached trial ended in a jury award of $1 million in damages and $5 million in punitive damages after a resident of Hillcrest Convalescent Home developed severe infected bedsores and died. Before filing for bankruptcy, Genesis was spending roughly $8 million a month on legal defense and settlements. Plaintiffs’ attorneys have described a pattern in which the company pushed cases into arbitration, appealed, then negotiated installment settlements it later stopped paying.
Unpaid Settlements at the Time of the Filing
The bankruptcy’s most immediate impact fell on families who had already settled. A review of 155 settlement agreements found Genesis paid nothing in 85 cases and only part of what it owed in 70 others. Of $58 million the company had promised, $41 million was still owed when the Chapter 11 automatic stay froze payments.
Individual cases show what that meant:
- Nancy Hunt’s family in Pennsylvania was owed $1.4 million of a $3.5 million August 2024 settlement after Hunt died from a severe foot injury. A local judge ordered payment, but the bankruptcy court stayed the order.
- A $925,000 settlement reached in May 2025 for an Albuquerque claimant known as “R.S.” went entirely unpaid.
- James Sanderson, also in Albuquerque, saw nothing on a $500,000 settlement due in November 2025.
- Nellie Betancourt’s $650,000 New Mexico settlement, reached in April 2025, had its installment plan disrupted by the filing.
- Margarett Johnson’s Maryland settlement of $950,000 from October 2024 was missing its final $112,500 installment.
Genesis told the court that paying immediately would harm patient care, citing “unforeseen and exigent financial challenges.” John Anthony, a lawyer representing 340 personal injury claimants, said the company “never had any intention to honor these deals.”
The Rejected Insider Sale
Instead of a traditional reorganization, Genesis pursued a Section 363 sale of its assets. The initial stalking-horse bidder was an affiliate of ReGen Healthcare, meaning Genesis’s own controlling investor, Joel Landau, was effectively bidding to buy the chain back at a discount. The proposed deal included liability releases for Landau, his associate David Gefner, and their firms Pinta Capital and Perigrove, wiping out the ability of injured residents and their families to sue those individuals directly.
Senators Elizabeth Warren, Richard Blumenthal, and Peter Welch, along with Representative Maggie Goodlander, opened a formal investigation in October 2025 and later filed an amicus brief. They accused insiders of trying to “wipe away Genesis’s debts and claims to victims by selling the company at a discount to insiders,” and noted that only $15 million was earmarked for administrative and unsecured claims against $1.6 billion in debt. Genesis’s own chief restructuring officer acknowledged that unsecured creditors “may get nothing.”
On December 10, 2025, Judge Stacey G. Jernigan of the U.S. Bankruptcy Court for the Northern District of Texas refused to approve the sale. She declined to grant the liability releases for Landau and Gefner, saying: “There is no way I can approve these releases without him on the witness stand and me being convinced of his good faith.” She also found “too many irregularities” in the auction, including the exclusion of at least one bidder and the downplaying of a competing offer, and ordered the process redone under supervision of the U.S. Trustee’s Office. The ruling preserved claimants’ ability to pursue Landau and other individuals in future litigation.
The New Sale and What Families Can Expect
A one-day auction was held on January 13, 2026, jointly run by the debtors and a creditors’ committee with an estate broker and mediator involved. After five rounds, 101 West State Street, backed by California-based NewGen Health, won with a bid of about $1.015 billion. Genie 3 Partners was the backup bidder at $991 million. The Landau-affiliated entity that had won the rejected December auction was not named in the results.
Judge Jernigan approved the sale on January 20, 2026. NewGen’s chief financial officer, Shawn Zhou, testified that Landau and Gefner had no involvement in the acquisition. Questions were raised during the hearing about whether 101 West’s owners were seeking a $35 million loan from Daryl Hagler, owner of Centers Health Care, who is facing nursing home fraud cases in New Jersey and New York. Zhou testified the group could “easily replace” that financing if needed.
For creditors, the new deal is a meaningful upgrade. Anthony estimated the 101 West sale would return roughly 30 cents on the dollar to junior creditors, compared to about 17 cents under the rejected insider bid. Transition of facilities to the new owner was expected to be completed in spring 2026 or later. Families holding unpaid settlements and pending injury claims will be paid from that pool rather than in full, and the exact distribution depends on the bankruptcy court’s allocation among creditor classes.
The Suit Against Landau and Gefner
A separate fight is now live over roughly $96 million in secured term loans held by Landau and Gefner’s entities, WAX Dynasty Partners and MAO 22322 LLC. In March 2026, Genesis and the court-appointed creditors’ committee sued the investors, alleging that debt transactions within two years of the bankruptcy filing were “made with the actual intent to hinder, delay, or defraud” creditors. The plaintiffs argue the investors bought debt that landlord Welltower had been considering forgiving, effectively manufacturing claims against the estate.
In a June 2026 motion to dismiss, attorneys for the investors said the transactions were structured for legitimate tax efficiency and that their 2024 deal with Welltower saved Genesis $10 million in annual rent. Landau and Gefner said they have no further strategic interest in Genesis and are entitled to repayment on valid secured claims. Judge Jernigan is hearing the dispute, with hearings scheduled through August 2026. If the plaintiffs succeed, the $96 million now claimed by insiders could instead flow to unsecured creditors, including injury and wrongful death claimants.
How Genesis Ended Up Here
The financial collapse behind the lawsuits traces back to a series of private equity deals. In 2007, Formation Capital and JER Partners took Genesis private in a leveraged buyout valued at about $1.7 billion, with the debt placed on the company’s own books. In 2011, Genesis sold 147 skilled nursing and assisted living facilities to Health Care REIT (now Welltower) for $2.4 billion, then leased them back under a 15-year triple-net master lease with rent starting at $198 million a year and escalating annually. The Private Equity Stakeholder Project characterized the transaction as one that “stripped Genesis of the property” while leaving the operator responsible for rent, taxes, insurance, and maintenance on buildings it no longer owned.1https://www.privateequitystakeholder.org/
Landau’s ReGen Healthcare took control in 2021 with a $100 million investment over two years, receiving a 93 percent equity stake. Between 2021 and 2023, ReGen was issued $111.2 million in convertible subordinated notes. Congressional investigators found that after ReGen’s takeover, the share of Genesis facilities earning four- or five-star CMS quality ratings fell from 38 percent to 15 percent. The Centers for Medicare and Medicaid Services fined Genesis facilities $10 million for health standard violations from 2022 onward. Connecticut regulators closed the Quinnipiac Valley Center in Wallingford in 2022 after two resident deaths, and Genesis closed St. Joseph’s Center in Trumbull in 2025 after residents were evacuated twice over safety concerns.
By the time of the filing, Genesis operated about 175 centers in 18 states serving roughly 15,000 residents, down from more than 500 centers across 34 states in 2015. It entered bankruptcy with $708 million in secured debt and over $1.5 billion in unsecured debt, and chose the Northern District of Texas venue, which congressional investigators said Genesis selected because of favorable case law on liability releases and insider transactions.